![Cong Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cong Li
Chief Executive Officer at
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Net worth: 675 505 $ as of 30/09/2026
Profile
Cong Li is on the board of Shanghai Junshi Biosciences Co., Ltd. Mr. Li previously was General Manager & Director at Tonghua Dongbao Pharmaceutical Co., Ltd. Mr. Li received an undergraduate degree from the University of Tongji.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 1,27,020 ( 0.02% ) | 675 505 $ | 30/09/2026 | |
| 31/12/2025 | 0 ( -.--% ) | - $ | 30/09/2026 |
Cong Li active positions
| Companies | Position | Start |
|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Chief Executive Officer | 02/11/2021 |
Former positions of Cong Li
| Companies | Position | End |
|---|---|---|
| TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 03/03/2019 |
Suzhou Landing Biopharmaceutical, Inc.
 Suzhou Landing Biopharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Executive Officer | - |
Education of Cong Li
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Tongji University
 Tongji University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonghua Dongbao Pharmaceutical Co., Ltd.
 Tonghua Dongbao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells insulin raw material medicines, preparations and diabetes related medical devices | Health Technology |
Shanghai Junshi Biosciences Co., Ltd.
 Shanghai Junshi Biosciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures monoclonal antibody drugs | Health Technology |
Suzhou Landing Biopharmaceutical, Inc.
Suzhou Landing Biopharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Cong Li
